White Paper

The Industry's Shift To 100% Non-Destructive Container Closure Integrity Testing With USP <1207>

Source: Bosch Packaging Technology
The Industry’s Shift To 100% Non-Destructive Container Closure Integrity Testing With USP <1207>

By Mahmoud Hamada, Bosch Packaging Technology

In recent years, container closure integrity (CCI) testing has steadily moved up the pharmaceutical manufacturing agenda. Latest research has shown that not only ampoules are prone to CCI defects. Other primary packaging types such as vials, cartridges and syringes equally require thorough testing, especially when filled with lyophilized products. Consequently, the United States Pharmacopeia (USP) has been revising its General Chapter 1207, calling for more quantitative, validated CCI test methods. A significant shift is expected towards non-destructive technologies.